Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD‐based meta‐analysis of cohort studies

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Transfusion

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1537-2995.2008.02043.xPMID 19170998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program

  2008cited by this paper
• ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients.

  2008cited by this paper
• Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

  2008cited by this paper
• Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation.

  2007cited by this paper
• Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation.

  2007cited by this paper
• Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation

  2007cited by this paper
• Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO‐incompatible allogeneic haematopoietic stem cell transplantation

  2007cited by this paper
• Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation

  2007cited by this paper
• Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies

  2007cited by this paper
• ABO incompatible stem cell transplantation in children does not influence outcome

  2007cited by this paper
• Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation

  2006cited by this paper
• Major ABO‐incompatible hematopoietic stem cell transplantation: study of post‐transplant pure red cell aplasia and endothelial cell chimerism

  2006cited by this paper
• Lack of effect of donor–recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation

  2006cited by this paper
• ABO blood group barrier in allogeneic bone marrow transplantation revisited.

  2005cited by this paper
• Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation

  2005cited by this paper
• The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation

  2005cited by this paper
• ABO glycosyltransferases as potential source of minor histocompatibility antigens in allogeneic peripheral blood progenitor cell transplantation

  2005cited by this paper
• Is the ABO incompatibility a risk factor in bone marrow transplantation?

  2005cited by this paper
• Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning

  2004cited by this paper
• Meta-analyses based on abstracted data: a step in the right direction, but only a first step.

  2004cited by this paper
• ABO mismatch increases transplant‐related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation

  2003cited by this paper
• ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation.

  2003cited by this paper
• Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

  2002cited by this paper
• Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?

  2002cited by this paper
• Severe immune hemolysis after minor ABO‐mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning

  2002cited by this paper
• ABO‐incompatibility in solid organ transplantation

  2001cited by this paper
• Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.

  2000cited by this paper
• ABO‐incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen‐related toxicity

  1999cited by this paper
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

  1999cited by this paper
• Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation

  1999cited by this paper
• ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation

  1999cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.

  1998cited by this paper
• Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility.

  1997cited by this paper
• Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.

  1995cited by this paper
• Meta-analysis of the literature or of individual patient data: is there a difference?

  1993cited by this paper
• ABO-incompatible bone marrow transplantation.

  1992cited by this paper
• IMMUNOHEMATOLOGIC CONSEQUENCES OF MAJOR ABOMISMATCHED BONE MARROW TRANSPLANTATION

  1988cited by this paper

• Parous female donor is not inferior to the young male donor under the low-dose ATG/PTCy combination-based regimen for GVHD prophylaxis in haploidentical peripheral blood stem cell transplantation.

  2025cites this paper
• Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation

  2024cites this paper
• HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis

  2024cites this paper
• Bidirectional ABO Mismatch Is Associated With Elevated Mortality in Hematopoietic Stem Cell Transplantation: Insights From a Single-Center Experience

  2024cites this paper
• Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

  2024cites this paper
• [Unrelated donor selection for allogeneic hematopoietic stem cell transplantation: Recommendations from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

  2023cites this paper
• Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia

  2023influential citation
• Allogeneic hematopoetic stem cell transplant for patients with refractory T‐Cell lymphomas

  2023cites this paper
• Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors

  2023cites this paper
• Hematopoietic Stem Cell Sources and Donor Selection

  2021cites this paper
• Post–hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics

  2021cites this paper
• Efficacy and safety of hematopoietic stem cell transplantation for hematologic malignancies

  2021cites this paper
• ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies.

  2021influential citation
• Transfusion Therapy in Specific Clinical Situations

  2021cites this paper
• Sex still matters

  2021cites this paper
• ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes

  2021cites this paper
• Complications of ABO- and Non-ABO-incompatible Stem Cell Transplantations

  2020cites this paper
• Changes in Mean Corpuscular Volume and RBC Distribution Width Predict Erythrocyte Engraftment Following ABO-Incompatible Hematopoietic Stem Cell Transplantation.

  2020cites this paper
• Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia

  2020cites this paper
• The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

  2019influential citation
• Transfusion Approaches in the Transplanted Patient

  2019cites this paper
• Who is the best donor for haploidentical stem cell transplantation?

  2019cites this paper
• Donor Evaluation, Selection and Hematopoietic Stem Cell Mobilization, Procurement, and Manipulation

  2018cites this paper
• Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

  2018cites this paper
• Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil

  2018cites this paper
• Donor‐type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant

  2018cites this paper
• Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.

  2017cites this paper
• 29. Haematological Disease

  2017cites this paper
• ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT

  2017cites this paper
• Selecting the best haploidentical donor.

  2016cites this paper
• ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA‐matched peripheral blood hematopoietic cell transplantation after reduced‐intensity conditioning

  2016cites this paper
• Complex Transfusion Issues in Pediatric Hematopoietic Stem Cell Transplantation.

  2016cites this paper
• ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation

  2016cites this paper
• Impact of recipient ABH secretor status on outcome in minor ABO‐incompatible hematopoietic stem cell transplantation

  2015cites this paper
• Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT

  2015cites this paper
• ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

  2015cites this paper
• Transfusion support issues in hematopoietic stem cell transplantation.

  2015cites this paper
• Donor Selection in Allogeneic Stem Cell Transplantation

  2014cites this paper
• The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation

  2014cites this paper
• Production of anti‐ABO blood group antibodies after minor ABO‐incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice

  2013influential citation
• Donor selection for patients undergoing allogeneic hematopoietic SCT: assessment of the priorities of Canadian hematopoietic SCT physicians

  2013cites this paper
• Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation

  2013cites this paper
• Analysis of risk factors of cord blood transplantation for children

  2013cites this paper
• IgM anti-recipient ABO antibodies predict acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

  2013cites this paper
• Impact of donor characteristics and HLA matching on survival of chinese patients with hematologic malignancies undergoing unrelated hematopoietic stem cell transplantation.

  2012cites this paper
• Biological and Genetic Aspects of Donor-Recipient Matching in HSCT

  2012cites this paper
• Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

  2012cites this paper
• Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor

  2012cites this paper
• The Role of HLA in Cord Blood Transplantation

  2012cites this paper
• Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning.

  2011cites this paper
• Transfusion Therapy in Specific Clinical Situations

  2011cites this paper
• Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation

  2011cites this paper
• Blood and Fluid Management during Cardiac Surgery

  2011cites this paper
• Transfusion strategies in patients undergoing stem-cell transplantation

  2011cites this paper
• Factors influencing engraftment in HLA-haploidentical/mismatch related transplantation with combined granulocyte-colony stimulating factor-mobilized peripheral blood and bone marrow for patients with leukemia.

  2011cites this paper
• Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Acute Leukemia: The Role of Meta-Analyses

  2010cites this paper
• . 동종조혈모세포이식에 ABO = Effect of ABO-incompatibility on Allogeneic Hematopoietic Stem Cell Transplantation - A Single Institute

  2009cites this paper
• Hematopoietic stem cell transplantation: is ABO “A match made in heaven”?

  2009cites this paper
• Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.

  2009cites this paper